Follow Us:

WhatsApp

E-mail

elaine@puruipharm.com

English
News

News

We are glad to share with you about the results of our work, company news, and give you timely developments and personnel appointment and removal conditions.
Company NewsIndustry News
Anticholinergic and emergency treatment APIs have passed multiple international quality validations.03 2026-04

Anticholinergic and emergency treatment APIs have passed multiple international quality validations.

Henan Purui Pharmaceutical Co., Ltd., a company with nearly two decades of experience in the field of specialty active pharmaceutical ingredients (APIs), recently announced that its anticholinergic and emergency
PURE Pharmaceuticals builds a high-end formulation CDMO service platform03 2026-04

PURE Pharmaceuticals builds a high-end formulation CDMO service platform

​Leveraging its deep expertise in active pharmaceutical ingredients (APIs), Henan Pury Pharmaceutical Co., Ltd. has achieved remarkable success
Puri Pharmaceuticals improves its intermediate industry layout03 2026-04

Puri Pharmaceuticals improves its intermediate industry layout

​In the entire pharmaceutical industry chain of "API-Intermediates-Formulation," pharmaceutical intermediates are a crucial link in ensuring product quality and cost advantages.
Deeply cultivate anticholinergic and emergency drug raw materials03 2026-04

Deeply cultivate anticholinergic and emergency drug raw materials

​As a core manufacturer of anticholinergic and emergency APIs in China, Henan Pury Pharmaceutical Co., Ltd. has continuously

Copyright © 2026 Henan Purui Pharmaceutical Co., Ltd. All Rights Reserved.

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy
RejectAccept